mTOR is often considered a downstream effector of numerous mutant oncogene pathways, such as the PI3K/Akt pathway and the Ras/Raf/Mek/Erk (MAPK) pathway, causing overactivation of mTOR and hence cancer [19]. The gene discussed is MTOR; the disease is cancer.